Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Arch Therapeutics’ AC5® Advanced Wound System Presents with Recognition at the 2021 Symposium .
Arch Therapeutics, Inc.May 10, 2021 GMT
FRAMINGHAM, Mass., May 10, 2021 (GLOBE NEWSWIRE) Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, presents two clinical case reports supporting the broad potential of AC5
® Advanced Wound System in chronic and non-healing wounds at the 2021 Symposium on Advanced Wound Care (SAWC) Spring this week. Both abstracts are available as Poster Presentations, and one abstract qualified for Podium Presentation in the Rapid Fire Symposium and earned a ribbon designation in the Poster Hall as the 2021 Highest Scoring Poster Abstract in the “Case Series/Study” category.